These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31465828)

  • 1. Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses.
    De Pasquale V; Pavone LM
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165539. PubMed ID: 31465828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
    Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Mucopolysaccharidoses, an Update.
    Fecarotta S; Tarallo A; Damiano C; Minopoli N; Parenti G
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis.
    Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Piotrowska E; Narajczyk M; Gabig-Cimińska M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive populations of basement membrane and cell membrane heparan sulfate proteoglycans are produced by cultured cell lines.
    Stow JL; Farquhar MG
    J Cell Biol; 1987 Jul; 105(1):529-39. PubMed ID: 2956272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential.
    Yang H; Wang L
    Adv Cancer Res; 2023; 157():251-291. PubMed ID: 36725112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
    De Pasquale V; Quiccione MS; Tafuri S; Avallone L; Pavone LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of Heparan Sulfate Proteoglycans in Development: Insights From Drosophila Models.
    Nakato H; Li JP
    Int Rev Cell Mol Biol; 2016; 325():275-93. PubMed ID: 27241223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
    Snow AD; Cummings JA; Lake T
    Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.
    Hull EE; Montgomery MR; Leyva KJ
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans in glomerular inflammation.
    Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
    Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
    De Pasquale V; Pavone LM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
    De Pasquale V; Sarogni P; Pistorio V; Cerulo G; Paladino S; Pavone LM
    Mol Ther Methods Clin Dev; 2018 Sep; 10():8-16. PubMed ID: 29942826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis.
    Koganti R; Memon A; Shukla D
    Semin Thromb Hemost; 2021 Apr; 47(3):283-294. PubMed ID: 33851373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.